Schrödinger is a New York-headquartered (NASDAQ: SDGR) computational science company that develops a physics-based and AI-driven molecular simulation platform used across drug discovery and materials science. Its flagship desktop modeling environment is Maestro (MS Maestro for materials science), which integrates a deep stack of computational tools — Glide (docking), FEP+ (free energy perturbation), Desmond (molecular dynamics), Jaguar (quantum chemistry), Prime (protein structure prediction), BioLuminate (biologics), LigPrep, QikProp, SiteMap, and WaterMap — together with the Schrödinger-maintained PyMOL visualization system. LiveDesign is the cloud-native enterprise design lab where chemists, biologists, and program teams collaborate on molecules, run computational workflows, and integrate experimental data; it exposes a snap-in API framework for connecting in-house and third-party tooling. The Schrödinger Python API (current release 2026-1) is the primary developer surface, providing programmatic access to molecular structures, Maestro automation, jobcontrol, Glide, FEP+, Desmond, Jaguar, MacroModel, Prime, BioLuminate, and LiveDesign integration (login, export, dataset and column management). Schrödinger also ships KNIME extensions, command-line drivers for every computational product, and maintains a meaningful open-source footprint on GitHub — including PyMOL, maeparser, coordgenlibs, sketcher, gpusimilarity, csmiles, and the fixed-data-table-2 React component. The business has two segments — software licensing to global pharma, biotech, and materials companies, and a co-developed and proprietary drug discovery pipeline. There is no public developer signup or self-serve REST API; access to the platform, Python API, and LiveDesign is gated through commercial licensing and the my.schrodinger.com customer portal.
Schrödinger is profiled on the APIs.io network. Tagged areas include Drug Discovery, Computational Chemistry, Molecular Simulation, Physics-Based Modeling, and Free Energy Perturbation.
Schrödinger’s developer surface includes developer portal, documentation, support, training material, tooling, engineering blog, YouTube channel, and 41 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/schrodinger: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
Online certification courses and a free learning portal for the platform
Drug discovery pipeline — proprietary and partnered programs including SGR-1505 (MALT1 inhibitor) and collaborations such as Lilly TuneLab integration into LiveDesign
Two-segment business — software licensing to global pharma, biotech, and materials companies plus a co-developed and proprietary drug discovery portfolio
Public company listed on NASDAQ under the ticker SDGR
Access is gated through commercial licensing and the my.schrodinger.com customer portal; no self-serve public REST API and no public developer signup
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →